Pharmaceutical companies are under increasing pressure to adopt more accurate, rapid, and comprehensive 100% testing methods to comply with regulations, meet market demands, and ensure long-term success. This includes testing raw materials, excipients, in-process parameters, and final products. Raman spectroscopy, approved by multiple pharmacopoeias, is a fundamental tool in drug development and quality assurance.

The JINSP RS1000DI drug identification instrument is a state-of-the-art device designed to ensure the highest standards of quality and safety in pharmaceutical manufacturing. It is capable of performing a meticulous 100% package-by-package inspection of raw materials and packaging materials, a process that is critical for maintaining the integrity of the drug production chain. This sophisticated instrument can quickly and accurately identify raw materials in various environments, including warehouses, material preparation rooms, and production workshops, where efficiency and precision are paramount.

The RS1000DI's advanced technology not only meets but exceeds the rigorous requirements of FDA 21 CFR Part 11, a regulation that sets the standard for electronic records and signatures in the pharmaceutical industry. Additionally, it adheres to the guidelines of Good Manufacturing Practice (GMP), ensuring that every product that leaves the facility meets the highest quality benchmarks. We, at JINSP, are deeply committed to the success of our clients and the safety of patients worldwide. In line with this commitment, we provide comprehensive technical support services that encompass method establishment, verification, and 3Q certification.

Wide Application Area:

Compact and lightweight, a single device can fulfill the requirements of multiple environments, including warehouses, material preparation rooms, and production workshops.